Add to Calendar 9/9/2019 10:00:00 AM 9/9/2019 5:00:00 PM Digital Health Impact 2019

Online registration is now closed, there will be a limited number of onsite registrations on Monday

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, reshaping clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our inaugural Digital Health Impact 2019 event at the InterContinental Boston at 510 Atlantic Ave, Boston, MA 02210, part of Biotech Week Boston, as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for life sciences and digital health innovators to converge and ultimately deliver better outcomes for patients. Contact Laura Rudberg for sponsorship opportunities. View our sponsorship prospectus here. 

 Intercontinental Boston, 510 Atlantic Avenue, Boston MA, 02210
Co-founder & General Partner, Flare Capital Partners
During Bill’s more than twenty-year tenure investing in young and emerging healthcare technology companies, he has served on the Boards of numerous industry-leading companies and played a critical role, actively helping and working closely with founders and management. His current firm’s healthcare investments include Aetion, Bright Health, ClearDATA, Curisium, HealthReveal, Intauleca, Valence Health (Evolent Health), and VisitPay. Prior to Flare Capital, Bill was at North Bridge Venture Partners since its inception in 1994. Previously, Bill was a Partner at Hambro International Equity Partners. Prior to that, he was Chief Financial Officer at MathSoft, a science and engineering applications software start-up that went public on the NASDAQ and was later acquired by a leading design and product lifecycle software solutions company, and was a CPA at Arthur Andersen & Company. Bill received a B.S. degree from Boston College and has served his alma mater in a variety of capacities, including former Chair of the Board of Trustees and current member of its Investment and Endowment Committee. He has been Chair of the Parents Committee of Duke University and Chair of the Stanford University Parents Advisory Board. Additionally, Bill is an appointee of Massachusetts Governor Charlie Baker to the Oversight Council of the Center for Health Information and Analysis, serves on the Advisory Council of the Department of Biomedical Informatics, the Discovery Council at Harvard Medical School and was selected by the Deputy Secretary of Health and Human Services to serve on the federal department’s innovation and investment summit.

Brought to you by